A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience
Condition:   Healthy Volunteers Interventions:   Drug: Soticlestat 300 mg;   Drug: Soticlestat 600 mg;   Drug: Soticlestat 900 mg;   Drug: Alprazolam;   Drug: Placebo Sponsor:   Takeda Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2022 Category: Research Source Type: clinical trials